LG Healthcare Valuation
| DOCT Etf | CHF 11.60 0.38 3.17% |
At this time, the etf appears to be undervalued. LG Healthcare Breakt owns a latest Real Value of ₣1.48 per share. The recent price of the etf is ₣11.6. Our model forecasts the value of LG Healthcare Breakt from analyzing the etf fundamentals such as net asset of 166.48 M, and One Year Return of 17.40 % as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that LG Healthcare's price fluctuation is relatively risky at this time. Calculation of the real value of LG Healthcare Breakt is based on 3 months time horizon. Increasing LG Healthcare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the DOCT etf is determined by what a typical buyer is willing to pay for full or partial control of LG Healthcare Breakthrough. Since LG Healthcare is currently traded on the exchange, buyers and sellers on that exchange determine the market value of DOCT Etf. However, LG Healthcare's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 11.6 | Real 1.48 | Hype 0.0 | Naive 11.01 |
The intrinsic value of LG Healthcare's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence LG Healthcare's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of LG Healthcare Breakthrough helps investors to forecast how DOCT etf's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of LG Healthcare more accurately as focusing exclusively on LG Healthcare's fundamentals will not take into account other important factors: About LG Healthcare Valuation
Our relative valuation model uses a comparative analysis of LG Healthcare. We calculate exposure to LG Healthcare's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of LG Healthcare's related companies.The investment objective of the LG Healthcare Breakthrough UCITS ETF is to provide exposure to the global healthcare technology industry. Robo Healthcare is traded on Switzerland Exchange in Switzerland.
Other Information on Investing in DOCT Etf
LG Healthcare financial ratios help investors to determine whether DOCT Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in DOCT with respect to the benefits of owning LG Healthcare security.